The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Open accessPublished version of a preprint
Abstract
BACKGROUND: Circulating lipoprotein lipids cause coronary heart disease (CHD). However, the precise way in which one or more lipoprotein lipid-related entities account for this relationship remains unclear. Using genetic instruments for lipoprotein lipid traits implemented through multivariable Mendelian randomisation (MR), we sought to compare their causal roles in the aetiology of CHD. METHODS AND FINDINGS: We conducted a genome-wide association study (GWAS) of circulating non-fasted lipoprotein lipid traits in the UK Biobank (UKBB) for low-density lipoprotein (LDL) cholesterol, triglycerides, and apolipoprotein B to identify lipid-associated single nucleotide polymorphisms (SNPs). Using data from CARDIoGRAMplusC4D for CHD (consisting of 60,801 cases and 123,504 controls), we performed univariable and multivariable MR analyses. Similar GWAS and MR analyses were conducted for high-density lipoprotein (HDL) cholesterol and apolipoprotein A-I. The GWAS of lipids and apolipoproteins in the UKBB included between 393,193 and 441,016 individuals in whom the mean age was 56.9 y (range 39-73 y) and of whom 54.2% were women. The mean (standard deviation) lipid concentrations were LDL cholesterol 3.57 (0.87) mmol/L and HDL cholesterol 1.45 (0.38) mmol/L, and the median triglycerides was 1.50 (IQR = 1.11) mmol/L. The mean (standard deviation) values for apolipoproteins B and A-I were 1.03 (0.24) g/L and 1.54 (0.27) g/L, respectively. The GWAS identified multiple independent SNPs associated at P < 5 × 10-8 for LDL cholesterol (220), apolipoprotein B (n = 255), triglycerides (440), HDL cholesterol (534), and apolipoprotein A-I (440). Between 56%-93% of SNPs identified for each lipid trait had not been previously reported in large-scale GWASs. Almost half (46%) of these SNPs were associated at P < 5 × 10-8 with more than one lipid-related trait. Assessed individually using MR, LDL cholesterol (odds ratio [OR] 1.66 per 1-standard-deviation-higher trait; 95% CI: 1.49-1.86; P < 0.001), triglycerides (OR 1.34; 95% CI: 1.25-1.44; P < 0.001) and apolipoprotein B (OR 1.73; 95% CI: 1.56-1.91; P < 0.001) had effect estimates consistent with a higher risk of CHD. In multivariable MR, only apolipoprotein B (OR 1.92; 95% CI: 1.31-2.81; P < 0.001) retained a robust effect, with the estimate for LDL cholesterol (OR 0.85; 95% CI: 0.57-1.27; P = 0.44) reversing and that of triglycerides (OR 1.12; 95% CI: 1.02-1.23; P = 0.01) becoming weaker. Individual MR analyses showed a 1-standard-deviation-higher HDL cholesterol (OR 0.80; 95% CI: 0.75-0.86; P < 0.001) and apolipoprotein A-I (OR 0.83; 95% CI: 0.77-0.89; P < 0.001) to lower the risk of CHD, but these effect estimates attenuated substantially to the null on accounting for apolipoprotein B. A limitation is that, owing to the nature of lipoprotein metabolism, measures related to the composition of lipoprotein particles are highly correlated, creating a challenge in making exclusive interpretations on causation of individual components. CONCLUSIONS: These findings suggest that apolipoprotein B is the predominant trait that accounts for the aetiological relationship of lipoprotein lipids with risk of CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypertriglyceridemia is indirectly linked with changes in HDL-C and LDL-C composition that are conducive to accelerated atherogenesis.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [312]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Evidence from prospective longitudinal cohort studies and Mendelian randomization support a strong, dose-dependent relationship between LDL-C levels and ASCVD incidence [2, 3].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“From this perspective, triglycerides chiefly index TRL particle burden rather than act as an independent atherogen, and causal inferences often attenuate when apoB is accounted for in multivariable genetic analyses [2].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the same time, it is important to recognize that apoB remains the most informative single summary measure of atherogenic risk, as LDL apoB numerically dominates total apoB in most individuals; accordingly, the benefits of lipid-lowering therapy appear to correlate more closely with reductions in apoB (particle number) than with triglyceride lowering alone [2, 18, 19].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We also highlight that apoB is the most robust integrative metric of atherogenic particle exposure, with some trial benefits aligning more strongly with apoB reduction than with triglyceride lowering alone [2, 18].”
From Targeting Triglycerides in Cardiovascular Disease Prevention: Evidence, Mechanisms, and Emerging Therapies (2026) · cites this paper as [2]
Experimental — accuracy not yet measured
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. (2011) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 13,726
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Second-generation PLINK: rising to the challenge of larger and richer datasets
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015) · Gigascience · doi:10.1186/s13742-015-0047-8 · Cited by 12,709
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922 · cited 2×
“The repertoire of robust univariable MR approaches [51] that seek to act as sensitivity analyses for potential unbalanced horizontal pleiotropy each make a different series of assumptions [53].”
BackgroundMethodThe UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Research works printed but not linked: 1
- D Fry, 2019, Companion Document to Accompany Serum Biomarker Data, UK Biobank Biomarker Project
Cited by
Items 201–300 of 903
Xie, Y., Liu, S., Wang, X., Huang, H., Wang, M., Qu, W., Yu, Z., Wang, W., & Luo, X. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032409 · Cited by 23
Impact of loss-of-function in angiopoietin-like 4 on the human phenome
Gagnon, E., Bourgault, J., Gobeil, É., Thériault, S., & Arsenault, B. J. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117558 · Cited by 17
Wu, Q., He, C., Huang, W., Song, C., Hao, X., Zeng, Q., Lan, D., & Su, Q. (2024) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2024-0017 · Cited by 21
Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease
Wadström, B. N., Borges, M. C., Wulff, A. B., Smith, G. D., Sanderson, E. C. M., & Nordestgaard, B. G. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.12.033 · Cited by 19
Self-citationTIGA: target illumination GWAS analytics
Yang, J. J., Grissa, D., Lambert, C. G., Bologa, C., Mathias, S. L., Waller, A., Wild, D. J., Jensen, L. J., & Oprea, T. I. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab427 · Cited by 16
Bell, J. A., Wade, K. H., O’Keeffe, L. M., Carslake, D., Vincent, E. E., Holmes, M. V., Timpson, N. J., & Smith, G. D. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003751 · Cited by 17
Self-citationAn Amish founder population reveals rare-population genetic determinants of the human lipidome
Montasser, M. E., Aslibekyan, S. W., Srinivasasainagendra, V., Tiwari, H. K., Patki, A., Bagheri, M., Kind, T., Barupal, D. K., Fan, S., Perry, J. A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03291-2 · Cited by 19
Almramhi, M. M., Finan, C., Storm, C. S., Schmidt, A. F., Kia, D. A., Coneys, R., Chopade, S., Hingorani, A. D., & Wood, N. W. (2023) · Neurology · doi:10.1212/wnl.0000000000207777 · Cited by 18
Remnant cholesterol traits and risk of stroke: A multivariable Mendelian randomization study
Wu, Z., Jiang, Y., Guo, Z., Li, P., Zheng, Y., Wang, Y., Zhang, H., Balmer, L. A., Li, X., Tao, L., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae033 · Cited by 17
Sex-Hormone-Binding Globulin Gene Polymorphisms and Breast Cancer Risk in Caucasian Women of Russia
Ponomarenko, I., Николаевич, П. К., Churnosova, M., Николаевна, С. И., Aristova, I., Churnosov, V., Ponomarenko, M., Reshetnikov, E., & Churnosov, M. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042182 · Cited by 19
Genome-Wide Mendelian Randomization Study Reveals Druggable Genes for Cerebral Small Vessel Disease
Yang, X., Huang, M., Han, F., Ni, J., Zhou, L., Yao, M., Zhang, D., & Zhu, Y. (2024) · Stroke · doi:10.1161/strokeaha.124.046544 · Cited by 18
Amyloid-beta metabolism in age-related neurocardiovascular diseases
Aivalioti, E., Georgiopoulos, G. A., Tual‐Chalot, S., Bampatsias, D., Delialis, D., Sopova, K., Drakos, S. G., Stellos, K., & Stamatelopoulos, K. S. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae655 · Cited by 24
Trinder, M., & Brunham, L. R. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000737 · Cited by 18
Liu, Z., & Mi, J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.712600 · Cited by 18
Sex-specific trajectories of molecular cardiometabolic traits from childhood to young adulthood
O’Keeffe, L. M., Tilling, K. M., Bell, J. A., Walsh, P. T., Lee, M. A., Lawlor, D. A., Smith, G. D., & Kearney, P. M. (2023) · Heart · doi:10.1136/heartjnl-2022-321347 · Cited by 20
Ten things to know about ten cardiovascular disease risk factors (“ASPC Top Ten – 2020”)
Bays, H. E. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100003 · Cited by 20
Wang, Z., Chen, S., Zhang, F., Akhmedov, S., Weng, J., & Xu, S. (2025) · Research · doi:10.34133/research.0618 · Cited by 22
A Comparison of Lipids and apoB in Asian Indians and Americans
Singh, K., Thanassoulis, G., Dufresne, L., Nguyen, A., Gupta, R., Narayan, K. M. V., Tandon, N., Sniderman, A. D., & Prabhakaran, D. (2021) · Global Heart · doi:10.5334/gh.882 · Cited by 17
Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease
Gagnon, É., Manikpurage, H. D., Mitchell, P. L., Girard, A. S., Gobeil, É., Bourgault, J., Bégin, F., Marette, A., Thériault, S., & Arsenault, B. J. (2023) · iScience · doi:10.1016/j.isci.2023.107127 · Cited by 16
Grussy, K., Łaska, M., Moczurad, W., Król-Kulikowska, M., & Ściskalska, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08894-4 · Cited by 16
Teng, D., Jia, W., Wang, W., Liao, L., Xu, B., Gong, L., Dong, H., Zhong, L., & Yang, J. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03804-3 · Cited by 21
Obesity-Dependent Association of the rs10454142 PPP1R21 with Breast Cancer
Ponomarenko, I., Николаевич, П. К., Churnosova, M., Николаевна, С. И., Aristova, I., Churnosov, V., Ponomarenko, M., Reshetnikova, Y., Reshetnikov, E., & Churnosov, M. I. (2024) · Biomedicines · doi:10.3390/biomedicines12040818 · Cited by 17
The epigenetic etiology of cardiovascular disease in a longitudinal Swedish twin study
Qin, X., Karlsson, I., Wang, Y., Li, X., Pedersen, N. L., Reynolds, C. A., & Hägg, S. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01113-6 · Cited by 18
Taba, N., Valge, H.-K., Metspalu, A., Esko, T., Wilson, J. F., Fischer, K., & Pirastu, N. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.738265 · Cited by 18
Yang, G., & Schooling, C. M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac562 · Cited by 17
Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults
Aguilar-Ramirez, D. J., Herrington, W. G., Alegre-Díaz, J., Staplin, N., Ramírez-Reyes, R., Gnatiuc, L., Hill, M., Romer, F., Trichia, E., Bragg, F., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00208-2 · Cited by 20
Li, N., Zhang, X., Zhang, M., Wu, L., Li, C., Pan, Y., Wang, W., Ji, J., & Zheng, D. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.02.001 · Cited by 14
Is hypertriglyceridemia a reliable indicator of cholesterol-depleted Apo B particles?
De Marco, D., Pencina, K., Pencina, M., Dufresne, L., Thanassoulis, G., & Sniderman, A. D. (2023) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2023.05.093 · Cited by 15
Николаевич, П. К. (2024) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2024-10-1-0-4 · Cited by 19
Xiong, Y., Tang, Y., Zhou, J. H. S., Tian, Y., Chen, F., Li, G., Huang, H., Huang, H., & Zhou, L. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035365 · Cited by 15
Huang, P., Zhao, Y., Wei, H., Wu, W., Guo, Z., Ma, S., Xu, M. M., Wang, Q., Jia, C., Xiang, T., et al. (2025) · International Journal of COPD · doi:10.2147/copd.s476833 · Cited by 16
Cho, H., Jin, H., & Eom, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.669215 · Cited by 14
Yoshikawa, M., Asaba, K., & Nakayama, T. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01127-2 · Cited by 15
Scapoli, C., Ziliotto, N., Lunghi, B., Menegatti, E., Salvi, F., Zamboni, P., Baroni, M., Mascoli, F., Bernardi, F., & Marchetti, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010310 · Cited by 15
O’Keeffe, L. M., Bell, J. A., O’Neill, K. N., Lee, M. A., Woodward, M., Peters, S. A. E., Smith, G. D., & Kearney, P. M. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003636 · Cited by 19
Shafique, H., Rehman, A., Nawaz, H., Majeed, M. I., Alshammari, A., Albekairi, N. A., Ali, A., Shahzadi, A., Yaseen, S., Sabah, N. U., et al. (2025) · Plasmonics · doi:10.1007/s11468-025-02785-z · Cited by 18
The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B
Webb, R. J., Mazidi, M., Lip, G. Y. H., Kengne, A. P., Banach, M., & Davies, I. G. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.12.004 · Cited by 14
Agongo, G., Raal, F. J., Nonterah, E. A., Debpuur, C. Y., Oduro, A. R., Ramsay, M., & Crowther, N. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278375 · Cited by 14
Deng, Z., Wang, H., Huang, K., Li, Y., Ran, Y., Chen, Y., & Zhou, L. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11604-6 · Cited by 18
The single-cell chromatin accessibility landscape in mouse perinatal testis development
Liao, J., Suen, H. C., Rao, S., Luk, A. C. S., Zhang, R., Lee, A. W.-T., Chan, T. H. T., Cheung, M. Y., Chu, H. T., So, H. C., et al. (2023) · eLife · doi:10.7554/elife.75624 · Cited by 15
Yamazaki, K., Terao, C., Takahashi, A., Kamatani, Y., Matsuda, K., Asai, S., & Takahashi, Y. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2934 · Cited by 14
Lu, J., Wang, Z., Zhang, J., Jiao, F., Zou, C., Han, L., & Jiang, G. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100528 · Cited by 15
Bilgic, S., Pencina, K. M., Pencina, M. J., Cole, J., Dufresne, L., Thanassoulis, G., & Sniderman, A. D. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321165 · Cited by 15
Chan, W. C., Liu, L., Bouras, E., Zuber, V., Wen, W., Long, J., Gill, D., Murphy, N., Gunter, M. J., Assimes, T. L., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02900-7 · Cited by 16
Khan, S. R., Ye, W. W., Van, J. A. D., Singh, I., Rabiee, Y., Rodricks, K. L., Zhang, X., Nicholson, R. J., Razani, B., Summers, S. A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1725 · Cited by 17
Grytten, E., Laupsa‐Borge, J., Bohov, P., Bjørndal, B., Strand, E., Skorve, J., Nordrehaug, J. E., Berge, R. K., Rostrup, E., Mellgren, G., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.040 · Cited by 15
Nutrient patterns are associated with discordant apoB and LDL: a population-based analysis
Mazidi, M., Webb, R. J., George, E. S., Shekoohi, N., Lovegrove, J. A., & Davies, I. G. (2021) · British Journal Of Nutrition · doi:10.1017/s000711452100369x · Cited by 15
Survival of Stem Cells and Progenitors in the Intestine Is Regulated by LPA5-Dependent Signaling
Liang, Z., He, P., Han, Y., & Yun, C. C. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.03.012 · Cited by 12
Lamri, A., Paoli, M. D., de Souza, R. J., Werstuck, G. H., Anand, S. S., & Pigeyre, M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.964743 · Cited by 17
Shapiro, D., Lee, K. D., Asmussen, J. K., Bourquard, T., & Lichtarge, O. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029103 · Cited by 14
Li, J., & Song, F. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01174-y · Cited by 14
Wang, Y., Zhang, Y., Zhao, C., Cai, W., Wang, Z., & Zhao, W. (2023) · Iranian Journal of Public Health · doi:10.18502/ijph.v52i10.13848 · Cited by 20
Wang, Z., Yang, X., Lu, J., Zou, C., Huang, W., Zhang, J., Liu, S. M., Han, L., Jiao, F., Tian, D., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117394 · Cited by 15
Ba, H., Zhang, L., Peng, H., He, X., & Wang, Y. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-024-00495-0 · Cited by 17
Blood lipids mediate the effects of gut microbiome on endometriosis: a mendelian randomization study
Su, C., Wan, S., Ding, J., Ni, G., & Ding, H. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02096-y · Cited by 15
LCoRL Regulates Growth and Metabolism
Wyler, S. C., Gahlot, S., Bideyan, L., Yip, C., Dushime, J., Chen, B., Lee, J. J., Tinajero, A., Limboy, C., Bordash, S., et al. (2024) · Endocrinology · doi:10.1210/endocr/bqae146 · Cited by 14
Yang, Z., Deng, Q., Hao, Y., Yang, N., Han, L., Jia, P., Zhou, P., Hao, Y., Wang, Z., Zhao, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54078-4 · Cited by 17
Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin Use
Wendt, F. R., Koller, D., Pathak, G. A., Jacoby, D. L., Miller, E. J., & Polimanti, R. A. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2260 · Cited by 15
Chilunga, F. P., Henneman, P., Venema, A., Meeks, K. A. C., González, J. R., Ruiz-Arenas, C., Requena‐Méndez, A., Beune, E., Spranger, J., Smeeth, L. L., et al. (2021) · Epigenomics · doi:10.2217/epi-2020-0329 · Cited by 14
Continental-scale genomic analysis suggests shared post-admixture adaptation in the Americas
Ongaro, L., Mondal, M., Flores, R., Marnetto, D., Molinaro, L., Alarcón-Riquelme, M. E., Moreno‐Estrada, A., Mabunda, N. J., Ventura, M., Tambets, K., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab177 · Cited by 16
The role of lipid traits in mediating the effect of body mass index on serum urate
Peng, L., Jing, J., He, S., Wang, J., Gao, X., & Wang, T. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.938891 · Cited by 15
Morris, J., Leung, S. S. Y., Bailey, M. E. S., Cullen, B., Ferguson, A., Graham, N., Johnston, K. J. A., Lyall, D. M., Lyall, L. M., Ward, J., et al. (2020) · Genes · doi:10.3390/genes11111326 · Cited by 14
Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism
Dai, W., Castleberry, M., & Zheng, Z. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.08.004 · Cited by 15
Nacarelli, G. S., Fasolino, T. K., & Davis, S. C. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad102 · Cited by 15
PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations
Holmes, M. V., Kartsonaki, C., Boxall, R., Lin, K., Reeve, N. F., Yu, C., Lv, J., Bennett, D., Hill, M., Yang, L., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae009 · Cited by 14
Self-citationHuang, G., Zhong, X., Zhang, M., Xu, M., Pei, B., & Qian, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-51523-8 · Cited by 15
Lee, Y., Yoon, J. W., Kim, Y. A., Choi, H. J., Yoon, B. W., & Seo, J. H. (2022) · Genes · doi:10.3390/genes13091553 · Cited by 13
Sandholm, N., Hotakainen, R., Haukka, J. K., Sigfrids, F. J., Dahlström, E. H., Antikainen, A. A., Valo, E., Syreeni, A., Kilpeläinen, E., Kytölä, A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01135-6 · Cited by 10
Boosting multivariate structured additive distributional regression models
Strömer, A., Klein, N., Staerk, C., Klinkhammer, H., & Mayr, A. J. (2023) · Statistics in Medicine · doi:10.1002/sim.9699 · Cited by 17
Mei, Y., Zhao, Z., Lyu, Y., & Li, Y. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01667-1 · Cited by 14
Liu, L., Wang, W., Si, Y., & Li, X. (2023) · The Journal of Dermatology · doi:10.1111/1346-8138.16910 · Cited by 15
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
Wadström, B. N., Wulff, A. B., Pedersen, K. M., & Nordestgaard, B. G. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01153-8 · Cited by 13
Zhang, H., Huang, Y., Zhang, J., Su, H., & Ge, C. (2023) · BMC Urology · doi:10.1186/s12894-023-01332-4 · Cited by 13
Yuan, W., Huang, M., Chen, X., Wu, J., Li, L., Wei, J., Lu, C., Han, L., & Lu, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1328297 · Cited by 14
Zheng, R., & Lind, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-61440-5 · Cited by 13
Wang, K., Shi, M., Luk, A. O. Y., Kong, A. P. S., Ronald, C. W., Li, C., Chen, L., Chow, E., & Chan, J. C. N. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02321-z · Cited by 12
Wang, L., Jiang, F., Sun, J., Zhao, J., He, Y., Gill, D., Burgess, S., Larsson, S. C., Yuan, S., & Li, X. (2025) · International Journal of Epidemiology · doi:10.1093/ije/dyaf020 · Cited by 12
Lu, Z., Jiao, Y., & Li, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.862942 · Cited by 12
Joo, J., Mak, A. C. Y., Xiao, S., Abou‐Sleiman, P. M., Hu, D., Huntsman, S., Eng, C. S., Kan, M., Diwakar, A. R., Lasky-Su, J. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16488-6 · Cited by 12
Mintoff, D., Pace, N. P., & Borg, I. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.962449 · Cited by 13
Hong, K. U., Salazar‐González, R. A., Walls, K. M., & Hein, D. W. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac103 · Cited by 14
Niu, P., Wang, X., & Xu, Y. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02028-0 · Cited by 11
Lecluze, E., & Lettre, G. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.07.011 · Cited by 13
Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study
Qin, H., Yang, F., Zhao, H., Zhao, J., Lin, S., Shang, Y., Zhang, C., Hao, P., & Zhang, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1185986 · Cited by 12
Wang, Q., Liu, Y., Xu, Z., Wang, Z., Xue, M., Li, X., & Wang, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1259579 · Cited by 11
Li, C., Wei, M., Mo, L., Velu, P., Prabahar, K., Găman, M., & Chen, M. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.10.020 · Cited by 11
Bayesian model comparison for rare-variant association studies
Venkataraman, G. R., DeBoever, C., Tanigawa, Y., Aguirre, M., Ioannidis, A. G., Mostafavi, H., Spencer, C. C. A., Poterba, T., Bustamante, C. D., Daly, M. J., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.11.005 · Cited by 11
Heart Failure and Ischemic Stroke: A Bidirectional and Multivariable Mendelian Randomization Study
Zhang, L., Liu, W., Sun, W., Wang, X., Tian, M., Pei, L., Liu, K., Liang, J., Zhou, L., Lu, J., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.771044 · Cited by 12
Liu, L. Y., Gu, Q., Hu, X., Fan, J., & Liu, X. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19510 · Cited by 12
Mitchell, R. E., Hartley, A. E., Walker, V. M., Gkatzionis, A., Yarmolinsky, J., Bell, J. A., Chong, A., Paternoster, L., Tilling, K. M., & Smith, G. D. (2022) · medRxiv · doi:10.1101/2022.04.22.22274166 · Cited by 11
Multi-Trait Genome-Wide Association Study of Atherosclerosis Detects Novel Pleiotropic Loci
Bellomo, T. R., Bone, W. P., Chen, B. Y., Gawronski, K. A. B., Zhang, D., Park, J., Levin, M. G., Tsao, N. L., Klarin, D. M., Lynch, J. A., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.787545 · Cited by 12
He, Q., Wang, W., Li, H., Xiong, Y., Tao, C., Ma, L., & You, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230623 · Cited by 10
Regulation of Mitochondria-Derived Immune Activation by ‘Antiviral’ TRIM Proteins
Oh, S., & Mandell, M. A. (2024) · Viruses · doi:10.3390/v16071161 · Cited by 10
Lin, C., Xia, M., Dai, Y., Huang, Q., Sun, Z., Zhang, G., Luo, R., Peng, Q., Li, J., Wang, X., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100810 · Cited by 14
Translating genetic association of lipid levels for biological and clinical application
Crone, B., Krause, A., Hornsby, W., Willer, C. J., & Surakka, I. L. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07156-4 · Cited by 10
Richardson, T. G., O’Nunain, K., Relton, C. L., & Smith, G. D. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316650 · Cited by 11
Self-citationSodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study
Zhao, S. S., Rajasundaram, S., Karhunen, V., Alam, U., & Gill, D. (2022) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2022.152058 · Cited by 10
Trius‐Soler, M., Mukamal, K. J., & Guasch‐Ferré, M. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000906 · Cited by 10
Jia, H., Liu, Y., & Liu, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1221228 · Cited by 14
Reijnders, E., van der Laarse, A., Ruhaak, L. R., & Cobbaert, C. M. (2024) · Clinical Proteomics · doi:10.1186/s12014-024-09465-w · Cited by 12
Metadata
- Authors
- Richardson, T. G., Sanderson, E., Palmer, T. M., Ala-Korpela, M., Ference, B. A., Davey Smith, G., & Holmes, M. V.
- Affiliations
- University of Bristol (GB)
- University of Cambridge (GB)
- Corresponding author
- Richardson, Tom G.
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-03-23
- Volume
- 17
- Issue
- 3
- Pages
- e1003062
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC7089422
- OpenAlex
- W3012570809
- Cited by
- 843
- References
- 79
- Citations by year
- 2026: 68 · 2025: 132 · 2024: 206 · 2023: 190 · 2022: 124 · 2021: 91 · 2020: 30
- FWCI
- 67.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Bristol Research (University of Bristol) (submittedVersion, cc-by-nc-nd)
- Explore Bristol Research (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_00011/1 and MC_UU-00011/2, MRC PHRU Oxford)
- UKRI (MR/S003886/1)
- National Health and Medical Research Council (APP1158958)
- Sigrid Juselius Foundation, Finland
- NIHR Cambridge Biomedical Research Centre
- British Heart Foundation (FS/18/23/33512)
- NIHR Oxford Biomedical Research Centre (Obesity theme)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- coronary artery disease, lipoprotein lipids, apolipoproteins, LDL cholesterol, triglycerides, HDL cholesterol, apolipoprotein B, apolipoprotein A-I, genetic instruments, causal inference, single nucleotide polymorphisms, genetic risk factors, UK Biobank
- MeSH terms
- Adult, Aged, Coronary Disease, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Phenotype, Risk Factors, Triglycerides, Biomarkers, Multivariate Analysis, Apolipoprotein A-I, Risk Assessment, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Apolipoprotein B-100, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.